Sofinnova Capital VI FCPR 13D/13G Filings for Ascendis Pharma A/S (ASND)

Sofinnova Capital VI FCPR 13D and 13G filings for Ascendis Pharma A/S:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-06-15
4:46 pm
Sale		 2021-05-20 13D Ascendis Pharma A/S
ASND		 Sofinnova Capital VI FCPR 4,978,993
9.700%		 -819,849decrease
(-14.14%)		 Filing
2021-02-02
5:28 pm
Sale		 2021-01-12 13D Ascendis Pharma A/S
ASND		 Sofinnova Capital VI FCPR 5,798,842
11.900%		 -1,018,708decrease
(-14.94%)		 Filing